XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Revenue (Tables)
 6 Months Ended
Jun. 30, 2022
Revenue From Contract With Customer [Abstract]  
Schedule Of Collaboration Revenue Revenue was as follows for the three and six months ended June 30, 2022 and 2021:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Neurocrine Biosciences:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Recognition of the transaction price

 

$

—

 

 

$

617

 

 

$

372

 

 

$

617

 

    Research and development services

 

 

536

 

 

 

1,601

 

 

 

1,806

 

 

 

2,959

 

    Milestone payments

 

 

—

 

 

 

—

 

 

 

7,124

 

 

 

—

 

Pacira BioSciences:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Milestone payments

 

 

—

 

 

 

—

 

 

 

—

 

 

 

3,000

 

Total collaboration revenue

 

$

536

 

 

$

2,218

 

 

$

9,302

 

 

$

6,576